• 1

    Samuelov L, Sarig O, Adir N et al.: Identification of clinically useful predictive genetic variants in pachyonychia congenita. Clin Exp Dermatol 46: 867, 2021.

  • 2

    Shah S, Boen M, Kenner-Bell B et al.: Pachyonychia congenita in pediatric patients: natural history, features, and impact. JAMA Dermatol 150: 146, 2014.

  • 3

    Wu AG, Lipner SR: Distinctions in the management, patient impact, and clinical profiles of pachyonychia congenita subtypes. Skin Appendage Disord 7: 194, 2021.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Stewart CL, Takeshita J, Hansen CD et al.: The histopathological features of the nail plate in pachyonychia congenita. J Cutan Pathol 47: 357, 2020.

  • 5

    Samuelov L, Smith F, Hansen C et al.: Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol 182: 738, 2020.

  • 6

    McLean WHI, Hansen CD, Eliason MJ et al.: The phenotypic and molecular genetic features of pachyonychia congenita. J Invest Dermatol 131: 1015, 2011.

  • 7

    Koren A, Sprecher E, Reider E et al.: A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma. Br J Dermatol 182: 671, 2020.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Eliason MJ, Leachman SA, Feng BJ et al.: A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol 67: 680, 2012.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Swartling C, Vahlquist A: Treatment of pachyonychia congenita with plantar injections of botulinum toxin. Br J Dermatol 154: 763, 2006.

  • 10

    González-Ramos J, Sendagorta-Cudós E, González-López G et al.: Efficacy of botulinum toxin in pachyonychia congenita type 1: report of two new cases. Dermatol Ther 29: 32, 2016.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Leachman SA, Kaspar RL, Fleckman P et al.: Clinical and pathological features of pachyonychia congenita. J Invest Dermatol Symp Proc 10: 3, 2005.

  • 12

    DeKlotz CMC, Schwartz ME, Milstone LM: Nail removal in pachyonychia congenita: patient-reported survey outcomes. J Am Acad Dermatol 76: 990, 2017.

  • 13

    Smith FJD, Hansen CD, Hull PR et al.:Pachyonychia Congenita,” in GeneReviews, edited by MP Adam, GM Mirzaa, RA Pagon et al., University of Washington, Seattle, 2006.

  • 14

    Nesher Shoshan H, Wehrt W: Understanding “Zoom fatigue”: a mixed-method approach. Appl Psychol 71: 827, 2021.

The Pachyonychia Congenita Virtual Support Group Meeting: Patient Insights and Pearls

Shari R. Lipner Weill Cornell, New York, NY.

Search for other papers by Shari R. Lipner in
Current site
Google Scholar
PubMed
Close
 MD, PhD
and
Julianne M. Falotico Stony Brook Medicine, Stony Brook, NY.

Search for other papers by Julianne M. Falotico in
Current site
Google Scholar
PubMed
Close
 MD

Corresponding author: Shari R. Lipner, MD, PhD, Weill Cornell, 1305 York Ave, New York, NY 10021. (E-mail: shl9032@med.cornell.edu)
Save